drugset / Trial / NCT03383081

The Safety/Efficacy of hUC Mesenchymal Stem Cells(19#iSCLife®-OA) Therapy for Patients With Osteoarthritis

NCT03383081

Phase 2 Recruiting 60 enrolled Sclnow Biotechnology Co., Ltd.
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is verify the efficacy and safety of Human Umbilical Cord Mesenchymal Stem Cells (UC-MSC) therapy for patients with Osteoarthritis, and in addition, provide basis for exploring the treatment regimen of UC-MSC therapy in different degree of cartilage defect disease

Timeline

Start
2018-10-01
Primary completion
2026-06-30
Completion
2026-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject SCLnow 19# Cell therapy 1e+07 cells Other
Subject SCLnow 19# Cell therapy 2e+07 cells Other

Indications